The Library
Using the precaution adoption process model to understand decision-making about the COVID-19 booster vaccine in England
Tools
Meyer, Carly, Goffe, Louis, Antonopoulou, Vivi, Graham, Fiona, Tang, Mei Yee, Lecouturier, Jan, Grimani, Aikaterini, Chadwick, Paul and Sniehotta, Falko F. (2023) Using the precaution adoption process model to understand decision-making about the COVID-19 booster vaccine in England. Vaccine, 41 (15). pp. 2466-2475. doi:10.1016/j.vaccine.2023.02.047 ISSN 0264-410X.
|
PDF
WRAP-Using-the-precaution-adoption-process-model-to-understand-decision-making-about-the-COVID-19-booster-vaccine-in-England-Grimani-2023.pdf - Publisher's Proof Version - Requires a PDF viewer. Download (596Kb) | Preview |
Official URL: https://doi.org/10.1016/j.vaccine.2023.02.047
Abstract
Background
COVID-19 continues to pose a threat to public health. Booster vaccine programmes are critical to maintain population-level immunity. Stage theory models of health behaviour can help our understanding of vaccine decision-making in the context of perceived threats of COVID-19.
Purpose
To use the Precaution Adoption Process Model (PAPM) to understand decision-making about the COVID-19 booster vaccine (CBV) in England.
Methods
An online, cross-sectional survey informed by the PAPM, the extended Theory of Planned Behaviour and Health Belief Model administered to people over the age of 50 residing in England, UK in October 2021. A multivariate, multinomial logistic regression model was used to examine associations with the different stages of CBV decision-making.
Results
Of the total 2,004 participants: 135 (6.7%) were unengaged with the CBV programme; 262 (13.1%) were undecided as to whether to have a CBV; 31 (1.5%) had decided not to have a CBV; 1,415 (70.6%) had decided to have a CBV; and 161 (8.0%) had already had their CBV. Being unengaged was positively associated with beliefs in their immune system to protect against COVID-19, being employed, and low household income; and negatively associated with CBV knowledge, a positive COVID-19 vaccine experience, subjective norms, anticipated regret of not having a CBV, and higher academic qualifications. Being undecided was positively associated with beliefs in their immune system and having previously received the Oxford/AstraZeneca (as opposed to Pfizer/BioNTech) vaccine; and negatively associated with CBV knowledge, positive attitudes regarding CBV, a positive COVID-19 vaccine experience, anticipated regret of not having a CBV, white British ethnicity, and living in East Midlands (vs. London).
Conclusions
Public health interventions promoting CBV may improve uptake through tailored messaging directed towards the specific decision stage relating to having a COVID-19 booster.
Item Type: | Journal Article | ||||||||
---|---|---|---|---|---|---|---|---|---|
Subjects: | B Philosophy. Psychology. Religion > BF Psychology R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine |
||||||||
Divisions: | Faculty of Social Sciences > Warwick Business School > Behavioural Science Faculty of Social Sciences > Warwick Business School |
||||||||
Library of Congress Subject Headings (LCSH): | Vaccine hesitancy -- England, COVID-19 (Disease) -- Vaccination -- England, Health Belief Model | ||||||||
Journal or Publication Title: | Vaccine | ||||||||
Publisher: | Elsevier Ltd. | ||||||||
ISSN: | 0264-410X | ||||||||
Official Date: | 6 April 2023 | ||||||||
Dates: |
|
||||||||
Volume: | 41 | ||||||||
Number: | 15 | ||||||||
Page Range: | pp. 2466-2475 | ||||||||
DOI: | 10.1016/j.vaccine.2023.02.047 | ||||||||
Status: | Peer Reviewed | ||||||||
Publication Status: | Published | ||||||||
Access rights to Published version: | Open Access (Creative Commons) | ||||||||
RIOXX Funder/Project Grant: |
|
Request changes or add full text files to a record
Repository staff actions (login required)
View Item |